Dan Pucheril

Husband, Father, Urologic Oncologist, Kettering Medical Center. RT≠E. Opinions my own.

[Firas Abdollah @DrFAbdollah]

In a 10-yr follow-up of a randomized trial, Retzius-sparing RARP (better early continence) showed worse long-term cancer control than the anterior approach — 2.64x higher progression risk after adjustment. Post-hoc, hypothesis-generating. free link:https://t.co/WhcUr6NCkK

[Dan Pucheril @dPuch]

@narendramodi @VivekGRamaswamy Viveks FIL is Dr. Ash Tewari! One of the world’s most accomplished urologists! Chair of the urology dept at Mt. Sinai!

[Dan Pucheril @dPuch]

@meelonmuskusa 56

[Bijan Salehizadeh @bijans]

Ok this clip about navigating the American Healthcare System from the recent South Park ozempic special (which was brilliant) needs to be the opening of every healthcare conference panel

[Michael Hofman @DrMHofman]

📢 LuTectomy online @EUplatinum📢 ✨
🔍 Findings: 🔹Effective targeted radiation 🔹Minimal side effects & surgical safety 🔹Potential new chapter in neoadjuvant therapy for HRCaP?
🔗 https://t.co/TxbedKupKr
🍾@RenuEapen @declangmurphy
💰@Movember

[Dan Pucheril @dPuch]

@sarahmorazz @MGHSurgery @harvardmed @MGHUrology Congrats!!

[Akshay Sood @Sood11]

Happy to share 15 y results of RARP in men w localized PCa diagnosed in the current PSA screen era. Few takeaways:
- longest FU, median >14 y
- detailed 5 onc/survival outcomes
- risk stratified w 608 and 312 IR and HR patients (lacking in ProtecT)
https://t.co/xn1saENABH

[Roderick van den Bergh @roodvdb]

🎯After 21 yrs in Rotterdam PCa screening study: Invite 246, diagnose 14 to prevent 1 death. Invite 121, diagnose 7 to prevent 1 metastatic case. Overdiagnosis now strongly reduced (risk stratification, MRI etc). Let's bring this advantage to all men who may benefit! @uroweb

[Dan Pucheril @dPuch]

@qdtrinh @Sood11 @Putnam_Cole @eau_yuo @Uroweb @Marco_Paciotti_ @mwvetterlein @EdoardoBeatrici @DrFAbdollah @Khalid_Alkhatib @FregoNicola @M_Koelker @DkFilipas @mdlabban @maxinesun Hahah. Yes Madrid was the best!! Good memories

[Dan Pucheril @dPuch]

@OSU_Urology @Sood11 @ctleeuro @OSUWexMed @OSUCCC_James Congrats!! Welcome to Ohio!

[Dan Pucheril @dPuch]

@dana_obery Gaaaaahhhh

[Akshay Sood @Sood11]

Important HSR session on how to do meaningful/actionable HSR research @qdtrinh @tkrupskiuro with @dPuch @Putnam_Cole @AlbertoMartini_ @drtanws @SuzanneKissel @ValGraj @TholomierC #SUO22

[Harry Thomas @DrHarryThomas]

"I've met my out-of-pocket maximum" season has officially begun in the United States.

[Vigen Malkhasyan @drvigen]

"Overflowing beer sign" and "angular interface". New allies helping to differentiate fpAML from RCC, with an excellent negative predictive value. Seems useful and easy to remember. Especially for beer lovers.😉

[Akshay Sood @Sood11]

W ongoing debate re #Retzius RP, we tried to comprehensively evaluate the anatomic principles behind early continence -- the key may be bladder neck preservation, not retzius @MMenonMD @DrFAbdollah @GrauerRalph @pjhensley11 @VattikutiUrol @MDAndersonNews
https://t.co/8IZF4NQiWW

[Matt Roberts @mj_robbo]

“Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy”
https://t.co/3jyMsk3KAX
Our new paper in EJNMMI @officialEANM

Here's the journey so far..
A🧵 1/6

#prostatecancer #pcsm #psma #PET

[Dan Pucheril @dPuch]

@jrlomax @HFleakyladies

[Dan Pucheril @dPuch]

@TheeRealMcKoy @AshleyGWinter Anatrophic nephrolithotomy!

[Elliot Servais, MD, FACS @ElliotServaisMD]

RVU based physician compensation models serve neither the patient nor the physician. Only the hospital business entity benefits

Change my mind…

[Yao Zhu @yao_zhu_sh]

SBRT for Lesions Detected via 68Ga-PSMA and 18F-FDG PET/CT in Patients with nmPCa with Early PSA Progression on ADT: A Prospective Single-center Study @EurUrolOncol https://t.co/tT5pbRLg1d